From: Active surveillance study of adverse events following immunisation of children in the Czech Republic
Type of adverse events following immunisation | Frequencya | Outset of symptoms (days after vaccination, mean -range in days) | Duration of symptoms (mean in days) |
---|---|---|---|
Local (rednes, swelling, pain) | 62.8% | 1.6 (1–8) | 5.2 |
Abscess in application site | 1.1% | 5.5 (2–10) | 16.0 |
Lymphadenitis | 1.7% | 20.9 (7–31) | 44.3 |
Fever | 26.8% | 1.3 (1–7) | 2.8 |
Alergic reaction | 0.6% | 0 (0) | 1.5 |
Posvaccinal exanthema | 4.5% | 3.3 (2–9) | 4.2 |
Arthralgia | 1.7% | 1.2 (1–5) | 13.2 |
Excessive crying | 4.2% | 0.9 (0–4) | 1.8 |
Hypotonic hyperactive epizode | 1.4% | 0 (0–1) | 0.3 |
Gastrointestinal disorders | 5.0% | 1.4 (0–5) | 2.2 |
Encephalopathy | 2.2% | 1.1 (1–7) | 4.0 |
Convulsions | 1.4% | 0.5 (0–1) | 0.5 |
Apnoe | 0.3% | 0.5 (0–1) | 1.0 |
Others | 8.4% | 1.3 (0–8) | 7.9 |